Skip to content
healthcare.dev

Roflumilast

NDC 70771-1674, Roflumilast, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1674
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208303
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1674 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST500 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
70771-1674-37077116740330 TABLET in 1 BOTTLE (70771-1674-3)
70771-1674-97077116740990 TABLET in 1 BOTTLE (70771-1674-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e87287bd-eae3-46c3-9072-04800aeabf40

Use it

Look up 70771-1674 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1674 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1674. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.